Profile data is unavailable for this security.
About the company
Fuso Pharmaceutical Industries, Ltd. is a Japan-based company principally involved in the manufacture and sale of pharmaceuticals and medical equipment for medical purposes. The Company operates in two business segments. The Pharmaceuticals segment is involved in manufacture and sale of pharmaceutical products, including injectable drugs, which mainly focus on infusion solution, dialysis fluid for artificial kidney, as well as the manufacture and sale of medical equipment and instruments. The Real Estate segment is engaged in the leasing of real estate properties.
- Revenue in JPY (TTM)57.72bn
- Net income in JPY2.20bn
- Incorporated1937
- Employees1.31k
- LocationFuso Pharmaceutical Industries Ltd1-7-10, Dosho-machi, Chuo-kuOSAKA-SHI 541-0045JapanJPN
- Phone+81 662316887
- Fax+81 669692341
- Websitehttps://www.fuso-pharm.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CanBas Co Ltd (Parent) | 0.00 | -1.31bn | 16.59bn | 11.00 | -- | 5.18 | -- | -- | -72.79 | -72.79 | 0.00 | 167.60 | 0.00 | -- | -- | 0.00 | -38.05 | -62.25 | -42.35 | -70.91 | -- | -- | -- | -2,015.62 | -- | -- | -- | -- | -- | -- | 2.77 | -- | -- | -- |
| Oncolys Biopharma Inc | 31.38m | -1.91bn | 16.70bn | 34.00 | -- | 7.75 | -- | 532.10 | -94.41 | -94.41 | 1.53 | 86.36 | 0.015 | 0.00 | 0.2917 | 923,058.80 | -91.65 | -45.75 | -104.28 | -51.86 | 0.00 | 60.46 | -6,093.40 | -233.66 | 9.72 | -102.93 | 0.1442 | -- | -93.54 | -17.86 | -68.72 | -- | 28.18 | -- |
| Stella Pharma Corp | 284.89m | -726.61m | 16.85bn | 44.00 | -- | 5.47 | -- | 59.13 | -22.94 | -22.94 | 8.91 | 90.49 | 0.061 | 0.0433 | 2.59 | 6,474,773.00 | -15.55 | -22.50 | -16.34 | -24.83 | 84.75 | -- | -255.05 | -488.65 | 17.82 | -563.58 | 0.217 | -- | 17.65 | -- | 1.94 | -- | -5.87 | -- |
| TAIKO PHARMACEUTICAL CO LTD | 6.28bn | -2.34bn | 18.23bn | 208.00 | -- | 2.24 | -- | 2.90 | -46.93 | -46.93 | 125.40 | 160.66 | 0.434 | 1.69 | 2.94 | 30,201,920.00 | -16.12 | -- | -19.68 | -- | 55.73 | -- | -37.15 | -- | 2.83 | -- | 0.2166 | -- | 21.43 | -- | 26.23 | -- | -- | -- |
| CellSeed Inc | 199.47m | -957.04m | 19.93bn | 35.00 | -- | 9.08 | -- | 99.90 | -30.72 | -30.72 | 6.40 | 63.29 | 0.0892 | 1.65 | 7.91 | 5,699,172.00 | -42.79 | -49.69 | -46.02 | -54.55 | 55.38 | 63.66 | -479.79 | -428.62 | 16.42 | -5,460.76 | 0.0651 | -- | 50.39 | -28.62 | -11.43 | -- | 80.73 | -- |
| Astena Holdings Co Ltd | 53.39bn | 2.09bn | 20.41bn | 1.40k | 9.46 | 0.6906 | 4.43 | 0.3823 | 52.62 | 52.62 | 1,341.82 | 721.11 | 0.7976 | 3.29 | 2.69 | 38,024,920.00 | 3.12 | 2.49 | 5.76 | 4.44 | 34.11 | 25.33 | 3.91 | 2.32 | 0.879 | 391.65 | 0.349 | 44.92 | 4.73 | -2.85 | 100.61 | -3.85 | 38.54 | 11.38 |
| StemRIM Inc | 0.00 | -2.02bn | 21.66bn | 44.00 | -- | 2.43 | -- | -- | -32.98 | -32.98 | 0.00 | 144.57 | 0.00 | -- | -- | 0.00 | -20.44 | -8.34 | -20.74 | -8.49 | -- | -- | -- | -68.74 | 131.03 | -11,344.72 | 0.00 | -- | -100.00 | -- | -1,301.17 | -- | -4.35 | -- |
| Fuso Pharmaceutical Industries Ltd | 57.72bn | 2.20bn | 24.70bn | 1.31k | 10.15 | 0.589 | 5.51 | 0.4278 | 257.39 | 257.39 | 6,774.96 | 4,436.49 | 0.7581 | 3.07 | 2.33 | 44,163,730.00 | 2.89 | 1.91 | 4.97 | 3.09 | 26.58 | 26.92 | 3.81 | 2.69 | 0.9406 | 50.75 | 0.267 | 41.10 | 8.61 | 3.76 | -14.21 | 9.02 | 9.13 | -2.64 |
| Daito Pharmaceutical Co Ltd | 47.40bn | 3.23bn | 31.77bn | 1.07k | 9.98 | 0.6088 | 4.63 | 0.6704 | 207.36 | 207.36 | 3,045.21 | 3,400.43 | 0.6178 | 1.86 | 2.76 | 44,294,390.00 | 3.90 | 6.27 | 5.08 | 8.24 | 20.28 | 22.65 | 6.32 | 8.47 | 1.29 | -- | 0.1891 | 19.59 | 3.98 | 2.66 | -8.47 | -1.27 | 11.37 | 11.67 |
| Fuji Pharma Co Ltd | 44.56bn | 6.36bn | 35.15bn | 1.62k | 5.42 | 0.7679 | 3.57 | 0.7888 | 261.79 | 261.79 | 1,833.31 | 1,849.15 | 0.5156 | 1.40 | 3.15 | 27,490,440.00 | 7.36 | 4.10 | 11.63 | 5.58 | 39.28 | 42.41 | 14.28 | 7.55 | 0.6276 | -- | 0.3912 | 31.17 | 15.42 | 1.52 | 27.41 | 0.3709 | 19.04 | 5.73 |
Data as of Nov 21 2024. Currency figures normalised to Fuso Pharmaceutical Industries Ltd's reporting currency: Japanese Yen JPY
11.16%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 07 Nov 2024 | 237.80k | 2.52% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 199.81k | 2.11% |
| Dimensional Fund Advisors LPas of 07 Nov 2024 | 166.76k | 1.76% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 15 Sep 2023 | 157.20k | 1.66% |
| Daiwa Asset Management Co. Ltd.as of 31 Oct 2024 | 107.10k | 1.13% |
| Nikko Asset Management Co., Ltd.as of 15 Sep 2023 | 89.80k | 0.95% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 25 Sep 2023 | 38.60k | 0.41% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 26.80k | 0.28% |
| Dimensional Fund Advisors Ltd.as of 07 Nov 2024 | 19.83k | 0.21% |
| Asset Management One Co., Ltd.as of 07 Nov 2024 | 10.80k | 0.11% |
More ▼
Data from 30 Jun 2024 - 14 Nov 2024Source: FactSet Research Systems Inc.
